The only thing SIERRA was good for was a reminder of the HUNDREDS OF MILLIONS of dollars spent by Roche and Pfizer in the past on FAILED research to find a way to activate p53. If KEVETRIN "WORKS", and we believe it will, then "YES" they will have some interest in CTIX. ,
(0)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links